Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease

Sayu Omori, Mariko Hida, Hisayo Fujita, Hisahide Takahashi, Susumu Tanimura, Michiaki Kohno, Midori Awazu

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

The expression of mitogen-activated protein kinases (MAPK) in DBA/2-pcylpcy (pcy) mice, a murine model of polycystic kidney disease was investigated. Proliferating cell nuclear antigen-positive cells were recognized in cyst epithelium from embryonic day 14.5 to 25 wk of age. Extracellular signal-regulated kinase (ERK) was expressed in the renal tubules of control and pcy mice, but stronger immunostaining was observed in cyst epithelium. Phosphorylated ERK was detected only in pcy mice and was localized predominantly in the cysts. p38 MAPK (p38) was no longer expressed after birth in controls but was detected in the cyst epithelium and in occasional tubular cells of pcy mice at all stages examined. c-Jun N-terminal kinase (JNK) was expressed in all tubular segments of controls after neonatal day 7, whereas in pcy kidneys, tubules became positive for JNK after 8 wk, and the cysts expressed little JNK. Administration of an oral MAP/ERK kinase inhibitor, PD184352, 400 mg/kg per d, to 10-wk-old pcy mice daily for the first week and then every third day for 6 additional weeks significantly decreased BP, kidney weight, serum creatinine level, and water intake and significantly increased urine osmolality. The cystic index and expression of phosphorylated ERK and ERK were significantly lower in PD184352-treated pcy mice. These results demonstrate that the expression of MAPK is dysregulated in cyst epithelium and that inhibition of ERK slowed the progression of renal disease in pcy mice.

Original languageEnglish
Pages (from-to)1604-1614
Number of pages11
JournalJournal of the American Society of Nephrology
Volume17
Issue number6
DOIs
Publication statusPublished - 2006 Jun

Fingerprint

Polycystic Kidney Diseases
Extracellular Signal-Regulated MAP Kinases
Disease Progression
Cysts
JNK Mitogen-Activated Protein Kinases
Epithelium
p38 Mitogen-Activated Protein Kinases
Mitogen-Activated Protein Kinases
Kidney
Kidney Tubules
Proliferating Cell Nuclear Antigen
Contraception
Osmolar Concentration
Drinking
Oral Administration
Creatinine
Phosphotransferases
Urine
Weights and Measures
Serum

ASJC Scopus subject areas

  • Nephrology

Cite this

Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease. / Omori, Sayu; Hida, Mariko; Fujita, Hisayo; Takahashi, Hisahide; Tanimura, Susumu; Kohno, Michiaki; Awazu, Midori.

In: Journal of the American Society of Nephrology, Vol. 17, No. 6, 06.2006, p. 1604-1614.

Research output: Contribution to journalArticle

Omori, Sayu ; Hida, Mariko ; Fujita, Hisayo ; Takahashi, Hisahide ; Tanimura, Susumu ; Kohno, Michiaki ; Awazu, Midori. / Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease. In: Journal of the American Society of Nephrology. 2006 ; Vol. 17, No. 6. pp. 1604-1614.
@article{aca908ba927b4bd0bc4095d039cee568,
title = "Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease",
abstract = "The expression of mitogen-activated protein kinases (MAPK) in DBA/2-pcylpcy (pcy) mice, a murine model of polycystic kidney disease was investigated. Proliferating cell nuclear antigen-positive cells were recognized in cyst epithelium from embryonic day 14.5 to 25 wk of age. Extracellular signal-regulated kinase (ERK) was expressed in the renal tubules of control and pcy mice, but stronger immunostaining was observed in cyst epithelium. Phosphorylated ERK was detected only in pcy mice and was localized predominantly in the cysts. p38 MAPK (p38) was no longer expressed after birth in controls but was detected in the cyst epithelium and in occasional tubular cells of pcy mice at all stages examined. c-Jun N-terminal kinase (JNK) was expressed in all tubular segments of controls after neonatal day 7, whereas in pcy kidneys, tubules became positive for JNK after 8 wk, and the cysts expressed little JNK. Administration of an oral MAP/ERK kinase inhibitor, PD184352, 400 mg/kg per d, to 10-wk-old pcy mice daily for the first week and then every third day for 6 additional weeks significantly decreased BP, kidney weight, serum creatinine level, and water intake and significantly increased urine osmolality. The cystic index and expression of phosphorylated ERK and ERK were significantly lower in PD184352-treated pcy mice. These results demonstrate that the expression of MAPK is dysregulated in cyst epithelium and that inhibition of ERK slowed the progression of renal disease in pcy mice.",
author = "Sayu Omori and Mariko Hida and Hisayo Fujita and Hisahide Takahashi and Susumu Tanimura and Michiaki Kohno and Midori Awazu",
year = "2006",
month = "6",
doi = "10.1681/ASN.2004090800",
language = "English",
volume = "17",
pages = "1604--1614",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "6",

}

TY - JOUR

T1 - Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease

AU - Omori, Sayu

AU - Hida, Mariko

AU - Fujita, Hisayo

AU - Takahashi, Hisahide

AU - Tanimura, Susumu

AU - Kohno, Michiaki

AU - Awazu, Midori

PY - 2006/6

Y1 - 2006/6

N2 - The expression of mitogen-activated protein kinases (MAPK) in DBA/2-pcylpcy (pcy) mice, a murine model of polycystic kidney disease was investigated. Proliferating cell nuclear antigen-positive cells were recognized in cyst epithelium from embryonic day 14.5 to 25 wk of age. Extracellular signal-regulated kinase (ERK) was expressed in the renal tubules of control and pcy mice, but stronger immunostaining was observed in cyst epithelium. Phosphorylated ERK was detected only in pcy mice and was localized predominantly in the cysts. p38 MAPK (p38) was no longer expressed after birth in controls but was detected in the cyst epithelium and in occasional tubular cells of pcy mice at all stages examined. c-Jun N-terminal kinase (JNK) was expressed in all tubular segments of controls after neonatal day 7, whereas in pcy kidneys, tubules became positive for JNK after 8 wk, and the cysts expressed little JNK. Administration of an oral MAP/ERK kinase inhibitor, PD184352, 400 mg/kg per d, to 10-wk-old pcy mice daily for the first week and then every third day for 6 additional weeks significantly decreased BP, kidney weight, serum creatinine level, and water intake and significantly increased urine osmolality. The cystic index and expression of phosphorylated ERK and ERK were significantly lower in PD184352-treated pcy mice. These results demonstrate that the expression of MAPK is dysregulated in cyst epithelium and that inhibition of ERK slowed the progression of renal disease in pcy mice.

AB - The expression of mitogen-activated protein kinases (MAPK) in DBA/2-pcylpcy (pcy) mice, a murine model of polycystic kidney disease was investigated. Proliferating cell nuclear antigen-positive cells were recognized in cyst epithelium from embryonic day 14.5 to 25 wk of age. Extracellular signal-regulated kinase (ERK) was expressed in the renal tubules of control and pcy mice, but stronger immunostaining was observed in cyst epithelium. Phosphorylated ERK was detected only in pcy mice and was localized predominantly in the cysts. p38 MAPK (p38) was no longer expressed after birth in controls but was detected in the cyst epithelium and in occasional tubular cells of pcy mice at all stages examined. c-Jun N-terminal kinase (JNK) was expressed in all tubular segments of controls after neonatal day 7, whereas in pcy kidneys, tubules became positive for JNK after 8 wk, and the cysts expressed little JNK. Administration of an oral MAP/ERK kinase inhibitor, PD184352, 400 mg/kg per d, to 10-wk-old pcy mice daily for the first week and then every third day for 6 additional weeks significantly decreased BP, kidney weight, serum creatinine level, and water intake and significantly increased urine osmolality. The cystic index and expression of phosphorylated ERK and ERK were significantly lower in PD184352-treated pcy mice. These results demonstrate that the expression of MAPK is dysregulated in cyst epithelium and that inhibition of ERK slowed the progression of renal disease in pcy mice.

UR - http://www.scopus.com/inward/record.url?scp=33646948499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646948499&partnerID=8YFLogxK

U2 - 10.1681/ASN.2004090800

DO - 10.1681/ASN.2004090800

M3 - Article

C2 - 16641154

AN - SCOPUS:33646948499

VL - 17

SP - 1604

EP - 1614

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 6

ER -